A quantum leap in drug discovery



Recent Insight
  • Quantum Software Outlook 2022
    IBM continues to lead the quantum cloud, but faces real competition to service early quantum applications. Building the future of this market still looks like a long game. It may be more important to pick a partner with the right strategy than just to compare today’s product features. The post... Read more
  • Quantum Algorithms Outlook 2022
    In contrast to the hype, the early applications of quantum computers look modest. But they do exist. The talented teams developing quantum algorithms still have a fight on their hands to bring forward the date of true broad quantum advantage. What might be achieved and when? The post Quantum Algorithms... Read more
  • Quantum Software Outlook 2021
    IBM continues to dominate the quantum cloud. However access to new more powerful processors will increase competition in the early adopter market. Ideas for user-engagement and education continue to explode with innovation. In the long term, supporting developers is a challenge the conventional software industry understands, but don’t forget that... Read more
Latest News
Project Description

Computational protein drug design.
ProteinQure uses artificial intelligence and quantum computing for the computational design of protein drugs. Antibodies, peptides, and other protein-based drugs have low toxicity and are capable of targeting a broad range of biological targets outside the scope of traditional small molecule therapeutics. Due to their structural complexity and dynamic flexibility, novel protein-based drugs are challenging to discover. Our software enables the rational design of protein-based drugs via atomistic simulations of the protein folding and binding process.
ProteinQure is a Toronto based biotech firm. We create computational R&D tools to perform drug design in silico. We leverage quantum computing, molecular simulations and reinforcement learning to engineer novel therapeutics.

Protein drugs of tomorrow
Despite their inherent advantages, it is very difficult to design protein based therapeutics.
ProteinQure is building scalable technologies to aid in structure based protein design.

Protein Therapeutics
We design small peptide based therapeutics (including cyclic peptides).

Structure Based Design
Exploring protein structures without data or known crystal structures.

Frontier Technologies
Quantum computing, artificial intelligence and molecular dynamics simulations.

Scalable Approach
The first step to designing large protein-based drugs beyond the current paradigm.

Project Details
Visit Website